Literature DB >> 26826066

Pulmonary Kaposi's Sarcoma and Its Complications in the HAART Era: A Contemporary Case-Based Review.

Oleg Epelbaum1, Ronaldo Go2, Geminikumar Patel3, Sidney Braman4.   

Abstract

The early years of the acquired immunodeficiency syndrome (AIDS) epidemic introduced the global medical community to Kaposi's sarcoma (KS), a heretofore seldom encountered angiosarcomatous neoplasm associated with human herpesvirus-8. At that time, clinicians treating these KS patients were routinely exposed to the pulmonary manifestations of this malignancy, including characteristic airway lesions, peribronchovascular opacities, and the typically hemorrhagic pleural effusions. They also witnessed uncommon complications of pulmonary KS such as chylous effusions, diffuse alveolar hemorrhage, and immune reconstitution inflammatory syndrome. Since the advent of highly active antiretroviral therapy, the incidence of KS has steadily declined and with that so has clinician familiarity with this disease. Herein, we present four KS cases recently encountered at our institution that illustrate both typical manifestations of pulmonary KS as well as its thoracic complications. The case descriptions are followed by a review of these clinical entities with the aim of restoring awareness among frontline physicians of what is now a rare but not quite extinct AIDS-defining neoplasm.

Entities:  

Keywords:  AIDS; Chylopericardium; Chylothorax; Diffuse alveolar hemorrhage; Immune reconstitution inflammatory syndrome; Kaposi’s sarcoma

Mesh:

Year:  2016        PMID: 26826066     DOI: 10.1007/s00408-015-9830-7

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  33 in total

1.  Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.

Authors:  James H Gallafent; Susan E Buskin; Peter B De Turk; David M Aboulafia
Journal:  J Clin Oncol       Date:  2005-02-20       Impact factor: 44.544

2.  Kaposi's sarcoma. CT-radiographic correlation.

Authors:  D P Naidich; M Tarras; S M Garay; B Birnbaum; B J Rybak; R Schinella
Journal:  Chest       Date:  1989-10       Impact factor: 9.410

3.  Diagnosis of pulmonary Kaposi's sarcoma by detection of human herpes virus 8 in bronchoalveolar lavage.

Authors:  M Tamm; F Reichenberger; C E McGandy; A Stalder; A Tietz; P Dalquen; A P Perruchoud; G Cathomas
Journal:  Am J Respir Crit Care Med       Date:  1998-02       Impact factor: 21.405

4.  Trends in cancer risk among people with AIDS in the United States 1980-2002.

Authors:  Eric A Engels; Ruth M Pfeiffer; James J Goedert; Phillip Virgo; Timothy S McNeel; Steven M Scoppa; Robert J Biggar
Journal:  AIDS       Date:  2006-08-01       Impact factor: 4.177

Review 5.  Human immunodeficiency virus-associated pericardial effusion: report of 40 cases and review of the literature.

Authors:  Y Chen; D Brennessel; J Walters; M Johnson; F Rosner; M Raza
Journal:  Am Heart J       Date:  1999-03       Impact factor: 4.749

Review 6.  The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma.

Authors:  D M Aboulafia
Journal:  Chest       Date:  2000-04       Impact factor: 9.410

7.  Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.

Authors:  F Samaniego; P D Markham; R Gendelman; Y Watanabe; V Kao; K Kowalski; J A Sonnabend; A Pintus; R C Gallo; B Ensoli
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

8.  Pulmonary Kaposi's sarcoma in patients with acquired immune deficiency syndrome: a clinicopathological study.

Authors:  P J Fouret; J L Touboul; C M Mayaud; G M Akoun; J Roland
Journal:  Thorax       Date:  1987-04       Impact factor: 9.139

Review 9.  Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth.

Authors:  Cecilia Sgadari; Paolo Monini; Giovanni Barillari; Barbara Ensoli
Journal:  Lancet Oncol       Date:  2003-09       Impact factor: 41.316

10.  Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study.

Authors:  Emilio Letang; Jose M Almeida; Jose M Miró; Edgar Ayala; Irene E White; Carla Carrilho; Rui Bastos; Tacilta Nhampossa; Clara Menéndez; Thomas B Campbell; Pedro L Alonso; Denise Naniche
Journal:  J Acquir Immune Defic Syndr       Date:  2010-04       Impact factor: 3.731

View more
  5 in total

1.  Chylothorax in a patient with HIV-related Kaposi's sarcoma.

Authors:  Sonia Cherian; Onyeka Maureen Umerah; Muhammad Tufail; Rakesh K Panchal
Journal:  BMJ Case Rep       Date:  2019-01-22

2.  Pulmonary Kaposi Sarcoma without Respiratory Symptoms and Skin Lesions in an HIV-Naïve Patient: A Case Report and Literature Review.

Authors:  Cristina Micali; Ylenia Russotto; Alessio Facciolà; Andrea Marino; Benedetto Maurizio Celesia; Eugenia Pistarà; Grazia Caci; Giuseppe Nunnari; Giovanni Francesco Pellicanò; Emmanuele Venanzi Rullo
Journal:  Infect Dis Rep       Date:  2022-03-25

Review 3.  Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update.

Authors:  Kawalpreet K Aneja; Yan Yuan
Journal:  Front Microbiol       Date:  2017-04-20       Impact factor: 5.640

4.  Diagnostic and management considerations in the modern patient with AIDS: a case of concurrent disseminated Kaposi sarcoma and colesional Cryptococcus neoformans.

Authors:  Samuel Clay Williams; Jacob Sweeney; Lalitha Parameswaran
Journal:  BMJ Case Rep       Date:  2020-04-14

5.  Compartmentalized T cell profile in the lungs of patients with HIV-1-associated pulmonary Kaposi sarcoma.

Authors:  Tarisiro Matiza; Kathryn F Boyd; Rebecca A Lyall; Douglas S Kwon; Alan M McGregor; Suzanne Fiorillo; Thomas B Campbell; Margaret Borok; Björn Corleis
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.